All press releases

ALFASIGMA ACQUIRES THE ENTIRE SHARE CAPITAL OF SOFAR, AN ITALIAN PHARMACEUTICAL COMPANY


Alfasigma Group Redeploys CARNITENE® (L-carnitine) Business in the Chinese Market


Alfasigma launches diagnostic drug Lumeblue™ ahead of World Digestive Health on 29 May


Alfasigma inaugurates the new Research and Development center in Pomezia named after its founder Marino Golinelli


Alfasigma: Jacopo Murzi is the new General Manager of the Italy Business Unit


Alfasigma acquires Lumeblue™ (Methylene Blue MMX) rights for EU distribution, consolidating its Gastro-Intestinal portfolio


Alfasigma to expand its digital footprint


Alfasigma launches its first full digital hackathon - Alfathon


COVID-19 outbreak: Alfasigma donates over 100.000 euros to Romanian Hospitals


Alfasigma joins the global fight against COVID-19 participating to GEFACOVID Project


×

You’re entering Alfasigma global website

I agree